Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:692-702

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hata, K.
Right arrow Articles by Przyklenk, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hata, K.
Right arrow Articles by Przyklenk, K.

(Circulation. 1998;97:692-702.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Brief Antecedent Ischemia Attenuates Platelet-Mediated Thrombosis in Damaged and Stenotic Canine Coronary Arteries

Role of Adenosine

Katsuya Hata, MD, PhD; Peter Whittaker, PhD; Robert A. Kloner, MD, PhD; ; Karin Przyklenk, PhD

From the Heart Institute, Good Samaritan Hospital and Department of Medicine, Section of Cardiology, University of Southern California, Los Angeles.

Correspondence to Karin Przyklenk, PhD, Heart Institute/Research, Good Samaritan Hospital, 1225 Wilshire Blvd, Los Angeles, CA 90017-2395.

Background—Recent studies suggest that patients with angina before myocardial infarction exhibit improved recovery of coronary perfusion after thrombolysis by an as-yet-unknown mechanism. We therefore proposed that brief antecedent ischemia/reperfusion may, via release of adenosine, improve vessel patency in damaged and stenotic coronary arteries.

Methods and Results—Anesthetized dogs underwent coronary injury+stenosis, resulting in repeated cyclic variations in coronary blood flow (CFVs) caused by the formation/dislodgment of platelet-rich thrombi. Vessel patency was assessed for 3 hours after stenosis by quantification of the nadir of the CFVs, duration of total thrombotic occlusion (flow=0), and area of the flow-time profile (expressed as percent of baseline flowx180 minutes). In protocol 1, dogs received 10 minutes of coronary occlusion+10 minutes of reflow or a comparable 20-minute control period before injury+stenosis. The median nadir of the CFVs was higher (4.0 versus 0.3 mL/min), median zero flow duration per 30-minute time interval was shorter (0.4 versus 15.1 minutes), and mean percent flow-time area was greater (54±8% versus 28±9%) in dogs that received antecedent ischemia versus controls (P<.05). These benefits of antecedent ischemia/reperfusion were largely mimicked by a 10-minute intracoronary adenosine infusion (400 µg/min) in lieu of brief ischemia (protocol 2) and were abolished by administration of the adenosine A1/A2 receptor antagonist PD 115,199 (3 mg/kg IV) before brief antecedent coronary occlusion (protocol 3).

Conclusions—Brief antecedent ischemia attenuates subsequent platelet-mediated thrombosis in damaged and stenotic canine coronary arteries, due, in large part, to an adenosine-mediated mechanism.


Key Words: adenosine • ischemia • stenosis • thrombosis • platelets




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. A. Kloner, M. B. Forman, R. J. Gibbons, A. M. Ross, R. W. Alexander, and G. W. Stone
Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial
Eur. Heart J., October 2, 2006; 27(20): 2400 - 2405.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Ross, R. J. Gibbons, G. W. Stone, R. A. Kloner, R. W. Alexander, and for the AMISTAD-II Investigators
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II)
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1775 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Ottani, M. Galli, S. Zerboni, and M. Galvani
Prodromal Angina Limits Infarct Size in the Setting of Acute Anterior Myocardial Infarction Treated With Primary Percutaneous Intervention
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1545 - 1547.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, E. Lucchinetti, M. Uecker, T. Pasch, and M. C. Schaub
Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms
Br. J. Anaesth., October 1, 2003; 91(4): 551 - 565.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
E. o. Cosar and C. J. O'Connor
Hibernation, Stunning, and Preconditioning: Historical Perspective, Current Concepts, Clinical Applications, and Future Implications
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 115 - 140.
[Abstract] [PDF]


Home page
HeartHome page
D Rimar, E Crystal, A Battler, S Gottlieb, D Freimark, H Hod, V Boyko, L Mandelzweig, S Behar, and J Leor
Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction
Heart, October 1, 2002; 88(4): 352 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Mirabet, D. Garcia-Dorado, J. Inserte, J. A. Barrabes, R.-M. Lidon, B. Soriano, M. Azevedo, F. Padilla, L. Agullo, M. Ruiz-Meana, et al.
Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1134 - H1141.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. A. Kloner
Preinfarct angina and exercise: yet another reason to stay physically active
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1366 - 1368.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Przyklenk and R. A. Kloner
Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Yellon and A. Dana
The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality?
Circ. Res., September 29, 2000; 87(7): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Przyklenk and P. Whittaker
Brief Antecedent Ischemia Enhances Recombinant Tissue Plasminogen Activator-Induced Coronary Thrombolysis by Adenosine-Mediated Mechanism
Circulation, July 4, 2000; 102(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Hata, P. Whittaker, R. A. Kloner, and K. Przyklenk
Brief Myocardial Ischemia Attenuates Platelet Thrombosis in Remote, Damaged, and Stenotic Carotid Arteries
Circulation, August 24, 1999; 100(8): 843 - 848.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H.-S. V. Chen, S. C. Body, and S. K. Shernan
Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97.
[Abstract] [PDF]